American Society of Interventional Pain Physicians | June 20, 2018
ASIPP Offers 4 Courses June 29 - 30 in Orlando

Introducing Advanced Neuromodulation Course!
This one day didactic and one day cadaver lab will be offered at the advanced level.

Attendance in the Neuromodulation Level is limited to 2 stations with just 4 physicians at each station.

The Neuromodulation Advanced Course will include the following procedures:
1. Spinal cord stimulator trial – Conventional leads
2. Spinal cord stimulator trial – Newer leads
3. Spinal cord stimulator implant
4. Spinal cord stimulator and DRG implant
5. Intrathecal Infusion System
6. Peripheral Nerve Stimulation 

HOTEL: Reservation Group Call-In Center
Toll Free: 1.866.360.7395
Local: 407.503.9276
Fax: 407.503.9208

HOTEL: Reservation Group Call-In Center
Toll Free: 1.866.360.7395
Local: 407.503.9276
Fax: 407.503.9208

HOTEL: Reservation Group Call-In Center
Toll Free: 1.866.360.7395
Local: 407.503.9276
Fax: 407.503.9208
Methadone and buprenorphine reduce risk of death after opioid overdose
NIH research confirms effective treatments for opioid use disorder are underutilized.

A National Institutes of Health-funded study found that treatment of opioid use disorder with either methadone or buprenorphine following a nonfatal opioid overdose is associated with significant reductions in opioid related mortality. The research,  published today (link is external)  in the Annals of Internal Medicine, was co-funded by the National Institute on Drug Abuse (NIDA) and the National Center for Advancing Translational Sciences, both parts of NIH.
Study authors analyzed data from 17,568 adults in Massachusetts who survived an opioid overdose between 2012 and 2014. Compared to those not receiving medication assisted treatment, opioid overdose deaths decreased by 59 percent for those receiving methadone and 38 percent for those receiving buprenorphine over the 12 month follow-up period. The authors were unable to draw conclusions about the impact of naltrexone due to small sample size, noting that further work is needed with larger samples. Buprenorphine, methadone, and naltrexone are three FDA-approved medications used to treat opioid use disorder (OUD). 
The study, the first to look at the association between using medication to treat OUD and mortality among patients experiencing a nonfatal opioid overdose, confirms previous research on the role methadone and buprenorphine can play to effectively treat OUD and prevent future deaths from overdose.

How America got hooked on a deadly drug
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities

Purdue Pharma left almost nothing to chance in its whirlwind marketing of its new painkiller OxyContin.
From 1996 to 2002, Purdue pursued nearly every avenue in the drug supply and prescription sales chain — a strategy now cast as reckless and illegal in more than 1,500 federal civil lawsuits from communities in Florida to Wisconsin to California that allege the drug has fueled a national epidemic of addiction.
Kaiser Health News is releasing years of Purdue’s internal budget documents and other records to offer readers a chance to evaluate how the privately held Connecticut company spent hundreds of millions of dollars to launch and promote the drug, a trove of information made publicly available here for the first time.

Opinion: Exit From ObamaCare
A new association health plan rule may spur better alternatives.

One perverse effect of the Affordable Care Act is that corporate America escaped some of the onerous mandates that hurt small enterprises. The Trump Administration is now trying to mitigate that inequity with a rule on association health plans, or AHPs, and perhaps the result will be a durable and popular alternative to ObamaCare coverage.
On Tuesday the Labor Department rolled out a final rule on AHPs. The point is to allow more small businesses to join forces to offer health insurance, using economies of scale to reduce costs and diversify risk. This is how corporations and unions manage health insurance in the large group market, either by paying an outside issuer or self-insuring.
Some groups can form AHPs now, but on a very limited basis. The new rule would allow industry groups across the country and local chambers of commerce to set up plans, which heretofore hasn’t been allowed under Labor's interpretation of the Employee Retirement Income Security Act (Erisa). Free-lancers such as Lyft drivers could now also band together.

Access to this article may be limited

First Generic Versions of Suboxone Get FDA Approval for Opioid Dependence

The first generic versions of  Suboxone (buprenorphine and naloxone sublingual film) have been approved by the Food and Drug Administration (FDA) for the treatment of opioid dependence as part of a complete treatment plan that includes counseling and psychosocial support. 
The treatment combines  buprenorphine , a partial-opioid agonist, with  naloxone , an opioid antagonist. The approval is part of the FDA's ongoing effort to reduce the opioid epidemic. In a press statement, FDA Commissioner Scott Gottlieb, MD said “The FDA is taking new steps to advance the development of improved treatments for opioid use disorder, and to make sure these medicines are accessible to the patients who need them. That includes promoting the development of better drugs, and also facilitating market entry of generic versions of approved drugs to help ensure broader access." 

Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

Essentials of Interventional Techniques in Managing Chronic Pain Available for Order!
  • Comprehensive textbook of interventional techniques in managing chronic pain
  • Covers spinal interventional techniques, peripheral nerve blocks, sympathetic interventional techniques, soft tissue and joint injections and implantables
  • Step-by-step guidance backed up by the latest evidence

This comprehensive review covers the full and latest array of interventional techniques for managing chronic pain. Chapters are grouped by specific treatment modalities that include spinal interventional techniques, nonspinal and peripheral nerve blocks, sympathetic interventional techniques, soft tissue and joint injections, and implantables. Practical step-by-step and evidence-based guidance is given to each approach in order to improve the clinician's understanding. Innovative and timely, Essentials of Interventional Techniques in Managing Chronic Pain is a critical resource for anesthesiologists, neurologists, and rehabilitation and pain physicians.

MAT Tied to Fewer Deaths a Year after Opioid Overdose
But only three in 10 overdose survivors receive treatment

Treating opioid overdose survivors with buprenorphine or methadone was linked to a 40% to 60% drop in mortality 1 year later, but the treatments were significantly underused, an observational study found.
While both buprenorphine and methadone were tied to fewer all-cause and opioid-related deaths, only three in 10 overdose survivors received medication for opioid use disorder (OUD) in the year after overdose, reported Marc Larochelle, MD, MPH, of Boston Medical Center, and colleagues in the  Annals of Internal Medicine .

More Doctor Pay Tied To Patient Satisfaction And Outcomes

As insurance companies shift more reimbursement away from fee-for-service medicine, doctors and their practices are seeing more of their bonuses and pay hikes based on “value-based metrics such as patient satisfaction and outcome measures,” new reports on physician compensation indicate.
Physician staffing firm MerrittHawkins said  43% of its clients offering physicians a “production bonus” last year based the bonus “in whole or in part on value-based metrics such as patient satisfaction and outcome measures.” That compares to 39% in 2016 and 32% in 2015, according to  Merritt’s 2018 Review of Physician and Advanced Practitioner Recruiting Incentives.
It’s a trend that others who analyze doctor pay are also noticing as health insurers including Anthem, UnitedHealth Group, Aetna and Cigna shift more than half of their reimbursement to value-based models that pay doctors based on quality of care delivered and the health outcomes of their patients. That means more reimbursement to doctors is coming via bundled payments, accountable care organizations (ACOs), patient-centered medical home models and pay-for-performance contracts.

New AMA policies takes aim at drug shortages and poor EHR training for medical students
One new policy deems drug shortages an urgent public health crisis and seeks to have manufacturing sites deemed critical infrastructure.

The American Medical Association is taking aim at dangerous drug shortages and the need for better EHR education for physicians with two new policies that could change manufacturer infrastructure and medical education.
First, a newly adopted policy has declared drug shortages an urgent public health crisis, as many of the drugs currently in dangerously short supply are everyday commodities needed for patient care in all medical settings such as sterile intravenous products containing saline or other fluids. 
Shortages of these basic products and their containers significantly ramped up following the devastation wrought by Hurricane Maria in Puerto Rico, where most of the bags used in the U.S. are made.

May/June 2018 Issue Features

Systematic Reviews
  • Role of Unilateral Balloon Kyphoplasty for OVCSF
Comprehensive Review
  • Patters, Changes, and Trends in Prescription Opioid Dispensing in Canada
  • Stem Cells for the Treatment of Knee Osteoarthritis
Randomized Trials
  • Effect of Different Volumes on Pain Relief in Patients Receiving Fluoroscopic Guided Interlaminar Lumbar Epidural Steroid Injections
  • Noninferiority Trial Comparing Upper and Lower One-Third Joint Approaches for SI Join Injections
  • Efficacy and Safety of Bone-filling Mesh Container and Simple Percutaneous Balloon Kyphoplasty

Do Patients Care About Your White Coat? You Might Be Surprised
A new study shows that provider attire could matter more than you think

The question of appropriate ward garb is a problem for the ages. Compared to photo stills and films from the 1960s, the doctors of today appear like vagabonds. No ties, no lab coats -- scrub tops have become the norm for a number (a majority?) of hospital-based docs -- and even more so on the surgical wards and in the ER.
Past studies have addressed patient preferences for provider dress, but none like a release from last week.
From the University of Michigan comes a  physician attire survey  of a convenience sample of 4,000 patients at 10 U.S. academic medical centers. It included both inpatients and outpatients, and used the design of many previous studies, showing patients the same doctor dressed seven different ways. After viewing the photographs, the patients received surveys as to their preference of physician based on attire, as well as being asked to rate the physician in the areas of knowledge, trust, care, approachability, and comfort.

Percutaneous Electrolysis May Be Useful Adjunct for Subacromial Pain Syndrome

In patients with  subacromial pain syndrome , ultrasound-guided percutaneous electrolysis plus standard therapy and exercise may not bring additional benefits in terms of disability and pressure sensitivity compared with therapy and exercise alone, according to findings published in the  Journal of Pain .
Subacromial pain syndrome is a common cause of shoulder pain for which there is no consensus on effective treatment options. Needling therapies, which deliver controlled microtrauma to the involved tissue, have recently garnered interest as potential components of multimodal approaches to the management of subacromial pain syndrome.

State Society News 

July 19-22, 2018
FSIPP 2018 Annual Meeting, Conference, and Trade Show
Florida Society of Interventional Pain Physicians
One South County Road, Palm Beach, FL 33480
Click Here for more information

July 14, 2018
WVSIPP launches Regional Conference Series, WV PainCare
The West Virginia Society of Interventional Pain Physicians has created an educational series titled WV PainCare.
Huntington, WV - July 14, 2018
Lewisburg/Beckley, WV - October 20, 2018
Morgantown, WV - December 1, 2018
Click HERE for more information

Aug 17-19, 2018
Ohio and Kentucky SIPP Meeting
Click HERE for more information

July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
For more information, contact Karrie Kirwan at or Tara Morrison at or 770-613-0932.

Send in your state society meeting news to Holly Long,
ASIPP | Pain Physician Journal | Phone | Fax | Email